---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-007578"
form_type: "8-K"
ticker: "SGHT"
cik: "0001531177"
company_name: "Sight Sciences, Inc."
filed_at: "2023-03-13T23:59:59+00:00"
generated_at: "2026-06-18T04:24:01.880120+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Sight Sciences Q4 2022 revenue up 40% YoY to $20.5M; guides 2023 revenue $89-94M

## Summary
- Full-year 2022 revenue $71.3M (+46% YoY); Surgical Glaucoma $65.6M (+41%), Dry Eye $5.7M (+133%).
- Q4 2022 net loss $16.9M ($0.35/share) vs $15.9M loss ($0.34/share) in Q4 2021.
- Q4 2022 operating expenses $33.9M, down 10% sequentially from Q3 2022.
- OMNI facilities reached 941 and TearCare facilities grew to 1,042 as of Dec 31, 2022.
- 2023 revenue guidance $89M-$94M, representing 25%-32% growth over 2022.

## SEC filing metadata
- accession: 0000950170-23-007578
- form_type: 8-K
- ticker: SGHT
- cik: 0001531177
- company_name: Sight Sciences, Inc.
- filed_at: 2023-03-13T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1531177/000095017023007578/0000950170-23-007578-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1531177/000095017023007578/sght-20230313.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-007578
- JSON: https://secwatch.observer/filing/0000950170-23-007578.json
- Plain text: https://secwatch.observer/filing/0000950170-23-007578.txt

## Key facts
- Earnings Releases
  Sight Sciences, Inc. updated its year ending December 31, 2023 guidance (initiated).
  - Period: year ending December 31, 2023
  - Guidance: initiated
  - Result: guidance update
  source text: Sight Sciences, Inc. (the "Company") issued a press release announcing its financial results for the four quarter and year ended December 31, 2022 and providing guidance for the year ending December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531177/000095017023007578/0000950170-23-007578-index.htm
- Earnings Releases
  Sight Sciences, Inc. reported the fourth quarter ended December 31, 2022 results: revenue $20.5 million, net income $16.9 million, EPS $0.35 per share.
  - Period: the fourth quarter ended December 31, 2022
  - Revenue: $20.5 million
  - Net income: $16.9 million
  - EPS: $0.35 per share
  - Result: reported results
  source text: 31, 2023. Recent Financial Highlights • Generated 2022 total revenue of $71.3 million, an increase of 46% compared to 2021 • Generated fourth quarter 2022 total revenue of $20.5 million, an increase of 40% compared to the prior year period • Reduced fourth quarter 2022 operating expenses by $3.7 million versus the third quarter of 2022 • Improved total gross
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531177/000095017023007578/0000950170-23-007578-index.htm
- Earnings Releases
  Sight Sciences, Inc. reported the year ended December 31, 2022 results: revenue $71.3 million, net income $86.2 million, EPS $1.80 per share.
  - Period: the year ended December 31, 2022
  - Revenue: $71.3 million
  - Net income: $86.2 million
  - EPS: $1.80 per share
  - Result: reported results
  source text: quarter and year ended December 31, 2022 and issued financial guidance for the year ending December 31, 2023. Recent Financial Highlights • Generated 2022 total revenue of $71.3 million, an increase of 46% compared to 2021 • Generated fourth quarter 2022 total revenue of $20.5 million, an increase of 40% compared to the prior year period • Reduced fourth quarter
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531177/000095017023007578/0000950170-23-007578-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.